A detailed history of Sandler Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Sandler Capital Management holds 11,857 shares of LLY stock, worth $9.1 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares
11,857
Previous 11,121 6.62%
Holding current value
$9.1 Million
Previous $10.1 Million 4.33%
% of portfolio
1.5%
Previous 1.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $568,295 - $706,574
736 Added 6.62%
11,857 $10.5 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $565,398 - $709,051
780 Added 7.54%
11,121 $10.1 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $7.17 Million - $9.59 Million
-12,100 Reduced 53.92%
10,341 $8.04 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $11.8 Million - $13.9 Million
22,441 New
22,441 $13.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sandler Capital Management Portfolio

Follow Sandler Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandler Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Sandler Capital Management with notifications on news.